Patient Inclusion Criteria:  Diagnosis of AD/ADRD based on a combination of AD/ADRD codes or treatment with a pharmacologic therapy used for AD (e.g., donepezil, rivastigmine, galantamine, and memantine) in the 365 days prior to or on cohort entry date. Evidence of potentially inappropriate prescribing with antipsychotics, sedative-hypnotics, and strong anticholinergics within the past 3 months Age ≥50 years of age as of cohort entry date Continuous medical and pharmacy insurance coverage for at least the prior year  Patient Exclusion Criteria:  Evidence of residing in a nursing home or skilled nursing facility or receiving palliative care. Incomplete/missing prescriber ID or incomplete contact information for either patient or prescribing provider. On "do not contact" list  Provider Inclusion Criteria:  1. Prescribing provider associated with most recent prescribing of target drug.